To further investigate the anti-metastatic effects of DCBLD2-targeted therapy in vivo, we used a jetPEI nanocarrier as the vehicle for DCBLD2-specific siRNAs to inhibit DCBLD2 expression in tumor-bearing mice (Figure 7a). Here, DCBLD2 is linked to neoplasm.